Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03692884 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chongqing Diabetes Registry Study

Study acronym: CDR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 1, 2023 to Jul 1, 2030v3
  2. Primary endpoints: 2 to 1
    • Secondary endpoints: 5 to 6
    • Study title expanded, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.
Trial Details
NCT Number NCT03692884
Lead Sponsor Chongqing Medical University
Conditions
(from sponsor)		 Diabetes Mellitus
Related terms Diabetes Mellitus
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov